MACO - PHARMA BENELUX
0448.280.649 · rovalta.com · 09/11/2026
MACO - PHARMA BENELUX
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMACO - PHARMA BENELUX is a Private limited company incorporated in 1992. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mouscron. It employs on average 5,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0448.280.649
- Incorporation
- 28/09/1992
- Legal form
- Private limited company
- Registered office
- Rue de l'Echauffourée 1
7700 Mouscron · WallonieSee on map - Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 5,0 ETP
Joint committees (1)
- 207
Financials
Source · NBB, 20 filingsTrend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 3,7 M € | +1.1% | 3,6 M € | -4.5% | 3,8 M € | +1.5% | 3,8 M € | -9.6% | 4,2 M € |
| EBITDA | 72,3 k € | -60.2% | 181,8 k € | +60.5% | 113,2 k € | +151% | 45,2 k € | -62.8% | 121,5 k € |
| Operating result | 104,1 k € | -35.4% | 161,3 k € | +102% | 79,8 k € | +86.3% | 42,8 k € | -63.6% | 117,6 k € |
| Net result | 73,3 k € | -88.2% | 619,9 k € | +1150% | 49,6 k € | +147% | 20 k € | -96.5% | 579,7 k € |
| Balance sheet | |||||||||
| Equity | 3,1 M € | 0.0% | 3,1 M € | 0.0% | 3,1 M € | 0.0% | 3,1 M € | 0.0% | 3,1 M € |
| Total assets | 4,2 M € | -5.8% | 4,4 M € | +13.2% | 3,9 M € | +1.7% | 3,9 M € | -27.5% | 5,3 M € |
| Cash | 22,1 k € | -65.3% | 63,7 k € | -17.6% | 77,3 k € | +141% | 32,1 k € | +31.0% | 24,5 k € |
| Debts | 1,1 M € | -18.5% | 1,4 M € | +77.5% | 788,2 k € | +7.7% | 731,8 k € | -67.9% | 2,3 M € |
| Other | |||||||||
| Workforce | 5,0 ETP | 0.0% | 5,0 ETP | 0.0% | 5,0 ETP | 0.0% | 5,0 ETP | 0.0% | 5,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 11 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
GROUPE MACO PHARMA INTERNATIONAL | MandateDirector21/10/2021 → 2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
GROUPE MACO PHARMA INTERNATIONAL S. Etr. | Director21/10/2021 → 2021 accounts | ||
Frank SCHONFELD | Director01/11/2020 → 2020 accounts | ||
Yvan MALEPART | Director05/03/2018 → 2020 accountsManagerlisted until the 2017 accounts |
Other companies at this address
Rue de l'Echauffourée 1 7700 Mouscron| Company | CBE no. |
|---|---|
ALLUCO● Active | 1022.417.612 |
BIO-RCP● Active | 0821.736.884 |
Biral Lubricants● Active | 0404.285.211 |
BUREAU CNOCKAERT● Active | 0412.467.754 |
Chauffage Damien Corne● Active | 0423.127.460 |
Compagnie wallonne de l'habitat● Active | 1042.281.628 |
Exail Robotics Belgium● Active | 0703.970.768 |
GALION INDUSTRY● Active | 1044.378.412 |
HENSOLDT NEXEYA BELGIUM● Active | 0779.802.992 |
HUMAN 89● Active | 1031.543.431 |
IDT EXPRESS● Active | 0677.699.111 |
LABORATOIRES OXYFORM● Active | 0763.626.758 |
LAURENS FIRE PROTECTION● Active | 1034.017.327 |
MD SERVICES● Active | 0803.286.296 |
M.G.S.● Active | 0437.078.139 |
NEUHART BELGIUM● Bankrupt | 0861.639.419 |
PLANNING● Active | 0412.684.223 |
QUANTARA● Active | 1038.430.035 |
SODIFIL● Bankrupt | 0433.262.970 |
STRADAS PACKAGING● Bankrupt | 0876.870.793 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/07/2026 | 17/06/2025 | 06/06/2024 | 30/06/2023 | 30/05/2022 | 28/07/2021 |
| General meeting | 21/05/2026 | 16/05/2025 | 17/05/2024 | 19/05/2023 | 20/05/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 21/05/2026 | 06/07/2026 | French | |
| Full model | 31/12/2024 | 16/05/2025 | 17/06/2025 | French | |
| Full model | 31/12/2023 | 17/05/2024 | 06/06/2024 | French | |
| Full model | 31/12/2022 | 19/05/2023 | 30/06/2023 | French | |
| Full model | 31/12/2021 | 20/05/2022 | 30/05/2022 | French | |
| Full model | 31/12/2020 | 30/06/2021 | 28/07/2021 | French | |
| Full model | 31/12/2019 | 09/07/2020 | 14/10/2020 | French | |
| Full model | 31/12/2018 | 28/06/2019 | 30/08/2019 | French | |
| Full model | 31/12/2017 | 18/05/2018 | 24/07/2018 | French | |
| Full model | 31/12/2016 | 06/06/2017 | 28/08/2017 | French | |
| Full model | 31/12/2015 | 20/05/2016 | 30/08/2016 | French | |
| Full model | 31/12/2014 | 30/06/2015 | 31/08/2015 | French | |
| Full model | 31/12/2013 | 25/06/2014 | 30/08/2014 | French | |
| Full modelCorrection | 31/12/2012 | 28/06/2013 | 21/01/2014 | French | |
| Full model | 31/12/2012 | 28/06/2013 | 30/08/2013 | French | |
| Full model | 31/12/2011 | 18/05/2012 | 31/08/2012 | French | |
| Full model | 31/12/2009 | 21/05/2010 | 27/08/2010 | French | |
| Full model | 31/12/2008 | 15/05/2009 | 31/08/2009 | French | |
| Full model | 31/12/2007 | 16/05/2008 | 20/08/2008 | French | |
| Full model | 31/12/2006 | 18/05/2007 | 08/08/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 11 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
GROUPE MACO PHARMA INTERNATIONAL | MandateDirector21/10/2021 → 2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
GROUPE MACO PHARMA INTERNATIONAL S. Etr. | Director21/10/2021 → 2021 accounts | ||
Frank SCHONFELD | Director01/11/2020 → 2020 accounts | ||
Yvan MALEPART | Director05/03/2018 → 2020 accountsManagerlisted until the 2017 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates19/03/2025DEMISSIONS, NOMINATIONS
- Mandates22/12/2021DEMISSIONS, NOMINATIONS
- Mandates02/12/2020DEMISSIONS, NOMINATIONS
- Mandates19/08/2020STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DIVERS - DEMISSIONS, NOMINATIONS
- Mandates27/02/2019DEMISSIONS, NOMINATIONS
- Mandates26/03/2018DEMISSIONS, NOMINATIONS
- Registered office18/07/2017SIEGE SOCIAL
- Mandates15/04/2016DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de l'Echauffourée 1, 7700 MouscronCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00254515 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| MACO - PHARMA BENELUXCurrent | accounts 2006 → 2025 | Accounts 2025 · 2026-00254515 |
Events
- 2025Annual accounts 202573,3 k €↓
- 2024Annual accounts 2024619,9 k €↑
- 2023Annual accounts 202349,6 k €↑
- 2022Annual accounts 202220 k €↓
- 2021Annual accounts 2021579,7 k €↑
- 2020Annual accounts 2020461,1 k €↓
- 2019Annual accounts 2019583,6 k €↓
- 2018Annual accounts 2018669,5 k €↓
- 2017Annual accounts 2017773,1 k €↑
- 2016Annual accounts 2016616,6 k €↓
- 2015Annual accounts 2015948,5 k €↑
- 2014Annual accounts 2014896,3 k €↓
- 2013Annual accounts 2013995,4 k €↓
- 2012Annual accounts 20121,1 M €↓
- 2011Annual accounts 20111,2 M €↑
- 2009Annual accounts 2009192,5 k €↓
- 2008Annual accounts 20082 M €↓
- 2007Annual accounts 20075 M €↑
- 2006Annual accounts 20063 M €
- 28/09/1992IncorporationPrivate limited company